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Objectives: To assess patient satisfaction with and adherence to oral anticoagulant therapy and to identify predic-
tors of the two studied domains.
Methods: A cross-sectional study was conducted at the Cardiothoracic Clinic in Alshaab Teaching Hospital; Khar-
toum; Sudan during March-April 2015. A representative sample of patients on oral anticoagulant treatment was
recruited. Data was collected through face-to-face interview method using oral Anti-Clot Treatment Scale (ATCS)
to measure satisfaction and the 4-items Morisky Scale to measure adherence to therapy. Data was processed using
SPSS. Logistic regression analysis was performed. P value <0.05 was considered statistically significant.
Results: A total of 93 patients was included, of them 46 were males. Overall, 47 (50.5%) were classified as satisfied
with anti-clot treatment. Patients attained secondary and above educational level were approximately 8 times more
satisfied with their anti-clot treatment, compared to those educated below this level, [OR 7.9 (2.9–21.7), P < 0.001].
Similarly, patients currently working were found to be approximately 3 times more satisfied with warfarin therapy,
compared those who had no jobs, [OR 2.9 (1.1–7.6), P = 0.035]. Overall, 5.4% of the patients were found to be adherent
to warfarin therapy. No definite background characteristic variable was found to be associated with adherence to
treatment. No association was found between patient satisfaction and adherence to treatment, (P = 0.490).
Conclusions: Ensuring health education on warfarin together with continuous patients motivation are needed,
specifically among patients with low educational level. Efficient multidisciplinary effort from all healthcare provi-
ders is needed to make warfarin treatment more successful.
 2016 Production and hosting by Elsevier B.V. on behalf of King Saud University. This is an open access article
under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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ACTS Anti-clot Treatment Scale
OAT Oral Anticoagulant Treatment
VTE Venous Thromboembolism
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Thrombosis is a common pathology underlyingischemic heart disease, ischemic stroke, and
venous thromboembolism (VTE) [1]. Globally,
ischemic heart disease and ischemic stroke collec-
tively cause approximately 25% of deaths [1]. The
use of anticoagulant therapy has increased in
recent decades due to its documented efficacy
and its use in numerous disease states by millions
of patients [2].
Warfarin, the most commonly used oral anti-
coagulant, requires frequent laboratory monitor-
ing to ensure optimal therapeutic outcomes and
to minimize bleeding complications [3].
Management of patients on warfarin therapy is
difficult due to its narrow therapeutic index,
putting them at significant risk of life threaten-
ing bleeding complications or thromboembolism
[4]. Warfarin is known as one of the drugs
that most frequently causes adverse drug reac-
tions that require hospital admission and
increased length of hospitalization, accounting
for considerable morbidity, mortality, and extra
cost [5].
Treatment satisfaction is defined as the
individual’s rating of important attributes of the
process and outcomes of their treatment experi-
ence [6]. Multiple domains of satisfaction with
treatment include: condition improvement; the
disappearance of symptoms; drug efficacy;
absence of drug side effects; ease and conve-
nience; and impact on health relate quality of
life [7].
It has been documented that improving and
enhancing satisfaction with the therapeutic
regimen, are very important to the care of
patients with chronic illnesses [8]. Characteristics
of warfarin such as the need for a regular
blood testing, limitations of lifestyle (e.g. restric-
tions on diet and activities) and the fear of
bleeding can result in a reduction of both
patient satisfaction and quality of life [9]. Higher
satisfaction and adherence to warfarin therapy
was found to be associated among other factors
with good international normalized ratio control
[10].
The aims of this study were to measure patient
satisfaction with and their adherence to warfarin
therapy, to identify sociodemographic predictors
of the two studied domains and to identify the rela-
tionship between satisfaction and adherence, if
any.Please cite this article in press as: Eltayeb T.Y.M. et al., Satisfaction with
Sudanese patients, J Saudi Heart Assoc (2016), http://dx.doi.org/10.1016/j.jMethods
Study design
A cross-sectional study was conducted during a
1-month period (March–April 2015).
Setting and participants
The study was conducted among patients on
warfarin therapy at the Cardiothoracic Clinic in
Alshaab Teaching Hospital, Khartoum, Sudan.
The clinic was established in the 1950s, and is
managed by physicians.
Inclusion criteria
Adult (age >18 years) patients on warfarin ther-
apy due to any clinical indication (for a duration of
at least 2 months) and who attended the clinic for
follow-up were recruited. The period of 2 months
is the average time needed to adjust the therapeu-
tic dose of the medication. Verbal informed con-
sent was obtained from eligible patients. To
minimize selection bias, the patients’ medical his-
tories and history of starting warfarin were
obtained directly from the patients or their
records with the help of the attending staff.
Exclusion criteria
Patients who were taking warfarin for
<2 months, were incapable to communicate ver-
bally, were previously diagnosed with mental dis-
eases, or refused to participate in the study were
immediately excluded.
Sample size and sampling techniques
A convenience method of sampling was adopted
and a total of 93 patients was finally included.
Data collection
Data were collected through face-to-face inter-
view using a structured questionnaire by the prin-
ciple author (clinical pharmacist). The
questionnaire was composed of three parts:
1. Demographic characteristics (age, sex, residence, educa-
tional level, marital status, and employment status) and
indication for warfarin.and adherence to warfarin treatment: A cross-sectional study among
sha.2016.10.007
Table 1. Patients’ background characteristics.
Background characteristic Frequency Percentage
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ADHERENCE TO WARFARIN TREATMENT2. Patient satisfaction with anticoagulant treatment using the
anticlot treatment scale (ACTS). The ACTS is a standard-
ized tool that has been used in previous studies. It is a 17-
item patient-report measure of satisfaction with anticoagu-
lant treatment. It includes 13 items about the burdens of
ACT (including a 12-item burdens scale and one global
question about the treatment burden) and four items about
the benefits of anticoagulants (including a 3-item benefits
scale and 1 global question about treatment benefits). The
tool was translated into Arabic Language as per Mapi
Research Institute guidance and previously used by Elbur
et al. [11] in a study in another Arabic country. To account
for the difference in dialect between Sudanese and Saudi
patients, the questionnaire was revised by the authors inde-
pendently and no major observation or change in the con-
struction was made. The patients were asked to rate their
experiences of anticoagulant treatment during the past
4 weeks on a five-point scale of intensity (1 = not at all,
2 = a little, 3 = moderately, 4 = quite a bit, 5 = extremely).
Reverse coding was adopted for the calculation of burden
scale in order that higher scores indicated higher satisfac-
tion. The Burden subscale score took values between 12
and 60 and the Benefit subscale score ranged from 3 to 15
to end up with a total range of 15–75 for all the seventeen
items. The patient was considered satisfied with anticlot
treatment if they scored above the mean score for all
patients and dissatisfied if their score was below this cutoff
point.
3. Adherence to oral anticoagulant therapy. Medication non-
adherence was measured using the self-reported four-
item Morisky scale [12], which assesses patient forgetful-
ness about taking medications, carelessness about taking
medications, stopping medication when feeling better, and
stopping medication when feeling worse. Questions were
answered as yes and no and scored one point for yes and
zero point for a no response. Scores were summed to give
a total score, ranging from 0 to 4. Nonadherence was
defined as a score greater than zero.Sex
Male 46 49.5
Female 47 50.5
Age group
<60 y 54 58.1
>60 y 39 41.9
Residence
Town 40 43.0
Outside town 53 57.0
Educational level
Below secondary 39 41.9
Secondary and above 54 58.1
Marital status
Married 70 75.3
Single 23 24.7
Occupation
Employee 12 12.9
Laborer 16 17.2
Private business 17 18.3
Housewife 22 23.7
Retired 9 9.7
Not working 17 18.3
Total 93 100Data analysis
Data were processed by SPSS version 20 (SPSS
Inc., Chicago IL, USA). Descriptive statistics were
used to describe all variables. The Chi-square test
was used to test the association between satisfac-
tion and adherence to treatment. Cronbach a
was used to measure the internal consistency reli-
ability of both ACTS and Morisky scale. Logistic
regression analysis was performed to identify pre-
dictors of satisfaction and adherence (sex, age in
years, residence, educational level, marital status,
and current working status). Crude logistic regres-
sion analyses were performed as initial steps of
qualifying covariates to be included in multivari-
ate logistic regression analyses. Covariates with
p < 0.05 were included in the final model. Finally,
variables with p < 0.05 on the multivariate logistic
model were considered as the predictors of satis-
faction with warfarin therapy.Please cite this article in press as: Eltayeb T.Y.M. et al., Satisfaction with
Sudanese patients, J Saudi Heart Assoc (2016), http://dx.doi.org/10.1016/j.jEthical approval
The study proposal was reviewed and approved
by the Ethics Committee, Ministry of Health,
Khartoum State, Khartoum, Sudan.Results
Demographic characteristics
A total of 93 patients were included; 47 (50.5%)
were female. Slightly more than 40% of the
patients were aged >60 years. There were 40 town
dwellers and 25 were illiterate (26.9%). Table 1
shows the distribution of patients by demographic
characteristics.Indications for warfarin
For 57 (61.3%) of the patients, warfarin was indi-
cated for mitral valve replacement. Indications for
warfarin are presented in Table 2.Satisfaction with warfarin therapy
The internal consistency of anticlot was found to
0.66. Mean scores to the items of ACTS are pre-
sented in Table 3. Overall, 47 (50.5%) of the
patients were classified as satisfied with anticlot
treatment.and adherence to warfarin treatment: A cross-sectional study among
sha.2016.10.007
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Table 2. Indications for warfarin.
Indication Frequency Percent
Mitral valve replacement 57 61.3
Atrial fibrillation 7 7.5
Pulmonary embolism 2 2.2
Deep vein thrombosis 1 1.1
Stroke 1 1.1
Others 25 26.8
Total 93 100
4 ELTAYEB ET AL
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2016;xxx:xxx–xxxPredictors of satisfaction with warfarin therapy
Initially, univariable analysis showed that male
sex, educational level, and having current jobs
were significantly associated with satisfaction with
warfarin therapy. However, on multivariate analy-
sis, patients who had attained secondary and
above educational level were approximately eight
times more satisfied with their anticlot treatment
than those educated below this level (odds ratio,
7.9; 95% confidence interval, 2.9–21.7; p < 0.001).
Similarly, patients who had current jobs were
found to be approximately three times more satis-
fied with oral anticoagulant treatment, than
respondents who were not working (odds ratio,
2.9; 95% confidence interval, 1.1–7.6; p = 0.035).
Table 4 shows predictors of patient satisfaction
with anticlot treatment.Adherence to warfarin
The internal consistency of Morisky scale was
found to be 0.71. Responses to the Morisky scale
items are shown in Table 5. Overall, 5.4% of theTable 3. Mean scores of participants’ responses to anticlot scale.
MItem
How much does the possibility of bleeding as a result of your anti
activity?
How much does the possibility of bleeding as a result of your ant
your usual activities?
How bothered are you by the possibility of bruising as a result o
How bothered are you by having to avoid other medicines as a
How much does your anticlot treatment limit what you eat and
How much of a hassle are the daily aspects of your anticlot treat
How much of a hassle (inconvenience) are the occasional aspect
How difficult is it to follow your anticlot treatment?
How time-consuming is your anticlot treatment?
How much do you worry about your anticlot treatment?
How frustrating is your anticlot treatment?
How much of a burden is your anticlot treatment?
Overall, how much of a negative impact has your anticlot treatm
How confident are you that your anticlot treatment will protect y
How reassured do you feel because of your anticlot treatment?
How satisfied are you with your anticlot treatment?
Overall, how much of a positive impact has your anticlot treatm
SD = standard deviation.
Please cite this article in press as: Eltayeb T.Y.M. et al., Satisfaction with
Sudanese patients, J Saudi Heart Assoc (2016), http://dx.doi.org/10.1016/j.jpatients were found to be adherent to warfarin
therapy. No definite background characteristic
variable was found to be associated with adher-
ence to treatment.
Association between patient satisfaction and
adherence to treatment
No association was found between patient satis-
faction and adherence to treatment (p = 0.490).Discussion
This study was carried out among patients on
oral warfarin to measure their satisfaction with
and adherence to treatment.
Analysis of the demographic variables of the
studied sample showed that 41.9% of the patients
were aged >60 years. Wieloch et al. [13], in a
follow-up study found that elderly patients are
predisposed to thromboembolic and bleeding
complications, despite the fact that their interna-
tional normalized ratios were within the target
therapeutic range.
More than 25% of the patients recruited in the
current study were illiterate. This was an impor-
tant demographic variable to be considered as
may affect anticoagulant control. Estrada et al.
[14] found a strong link between both low literacy
and numeracy and poor anticoagulation control.
Slightly more than 60% of the participants used
warfarin for the prophylaxis after mitral valve
replacement. According to McKenzie et al. [15]
the risk of valve thrombosis is five-fold and theMean
score ± SD
clot treatment limit you from doing physical 2.7 ± 1.4
iclot treatment limit you from taking part in 3.1 ± 1.3
f your anticlot treatment? 3.2 ± 1.2
result of your anticlot treatment? 3.3 ±1.3
drink? 3.5 ± 1.3
ment? 3.7 ± 1.2
s of your anticlot treatment? 3.2 ± 1.3
3.5 ± 1.3
3.7 ± 1.2
3.2 ± 1.3
3.0 ± 1.3
3.1 ± 1.3
ent had on your life? 2.8 ± 1.4
our health? 2.9 ± 1.3
2.6 ± 1.3
2.9 ± 1.3
ent had on your life? 2.9 ± 1.3
and adherence to warfarin treatment: A cross-sectional study among
sha.2016.10.007
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Table 4. Determinants of satisfaction with oral anticoagulant therapy.
Covariates % Satisfied n Univariable analysis
crude OR (95% CI)
p Multivariable analysis
adjusted OR (95% CI)
p
Sex
Female 40.4 46 1
Male 60.9 47 2.3 (1.0–5.3) 0.029
Age group
<60 y 48.1 54 1
>60 y 53.8 39 0.8 (0.3–1.8) 0.588
Residence
Outside town 45.3 53 1
Town 57.5 40 1.6 (0.7–3.7) 0.245
Educational level
Below secondary 20.5 39 1 1
Secondary & above 72.2 54 10.1 (3.8–26.8) <0.001 7.9 (2.9–21.7) <0.001
Marital status
Married 47.1 70 1
Single 60.9 23 0.6 (0.2–1.5) 0.256
Occupation
Not working 33.3 48 1 1
Working 68.9 45 4.4 (1.8–10.6) 0.001 2.9 (1.1–7.6) 0.035
Total 93
CI = confidence interval; OR = odds ratio.
Table 5. Responses to Morisky scale.
Yes (%) No (%)
Do you ever forget to take your warfarin? 28.0 72.0
Do you ever have problems remembering to take your warfarin? 31.2 68.8
When you feel better, do you sometimes stop taking your warfarin? 22.6 77.4
Sometimes if you feel worse when you take your warfarin, do you stop taking it? 26.9 73.1
J Saudi Heart Assoc
2016;xxx:xxx–xxx
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ADHERENCE TO WARFARIN TREATMENTrisk of major embolism increases 1.5-fold among
patients with mitral valves compared to those with
aortic ones.
In the current study, the ACTS was used to mea-
sure patient satisfaction. Although the tool was
validated for patients on anticoagulant treatment
for venous thromboembolism patients and pul-
monary embolism, it can also be used for patients
receiving long-term anticoagulation irrespective
of the underlying condition [16].
Overall, nearly half of the patients were classi-
fied as satisfied with anticlot treatment. Compara-
tively, in the above mentioned study, which was
conducted among Saudi patients, satisfaction
was higher (63.7%) [11]. Both studies used the
same tool to evaluate satisfaction with warfarin
therapy. The difference in the degree of satisfac-
tion between the two studied samples may be
attributed to the difference in demographic char-
acteristics of the patients, indications of warfarin,
and the level of patient education and their moti-
vation. In this respect, the univariable analysis in
both studies showed that men were to be morePlease cite this article in press as: Eltayeb T.Y.M. et al., Satisfaction with
Sudanese patients, J Saudi Heart Assoc (2016), http://dx.doi.org/10.1016/j.jsatisfied than women. Female sex was identified
among other factors to be associated with negative
perception regarding oral anticoagulant therapy
[17].
By contrast, analysis of a cohort of patients using
warfarin for thromboembolism prophylaxis after
total hip replacement concluded that 83.38% of
the patients were very or extremely satisfied with
oral antithrombotic medications [18]. Neither
sociodemographic characteristics nor the type of
concomitant treatment received showed differ-
ences in satisfaction with treatment. Again, the
difference in the level of satisfaction between the
studied samples may be attributed to the differ-
ence in the demographic characteristics of the
patients, indications for warfarin, and health sys-
tem factors.
Generally, to attain high satisfaction among
patients on warfarin therapy, the items of the
ACTS that cause burden, limit activity, limit food
and drinks, or cause frustration should be studied
in depth. In addition, female concerns and dissat-
isfaction are important areas for future research toand adherence to warfarin treatment: A cross-sectional study among
sha.2016.10.007
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group of patients.
Multivariate analysis showed that patients
attained secondary and above educational level
were approximately eight times more satisfied
with their anticlot treatment compared to those
educated below this level. Higher education,
clearly helps the patients to understand the edu-
cational message and improve their communica-
tion with healthcare providers. In addition, such
patients have the ability to come across consider-
able information about their disease state from
other sources that increase their level of aware-
ness and perception.
Unfortunately, only 5.4% of all patients were
found to be adherent to warfarin treatment. A
possible reason for the observed low rate of
adherence was the insensitivity of the recruited
patients to the Morisky scale. Future research is
needed to explore this issue in depth. The
observed low level of adherence did not allow
for statistical comparison to identify predictors of
this domain. However, certain patient demo-
graphic characteristics, such as advanced age,
low level of education and residence outside
towns may contribute to this finding. Other
researchers identified education below high
school, employment status, and impaired cogni-
tion as important factors associated with nonad-
herence to warfarin therapy [19].
Poor patient adherence documented in the cur-
rent was a serious finding and very important area
for further future researches. The issue of adher-
ence is certainly very complex. In-depth investiga-
tion of different factors related to both the patients
and the health care system is needed in order to
develop interventions to improve patient commit-
ment to therapy. In a recently published Sudanese
study, the researchers targeted both patient
knowledge about and adherence to warfarin, and
introduced an educational intervention [20]. Ver-
bal education by a clinical pharmacist and written
information were provided for the patients peri-
odically for 12 months. The intervention resulted
in a significant improvement in both studied
domains. Despite the fact that there were clinical
pharmacists appointed at the hospital where the
current study was conducted, a real clinical phar-
macy service was not provided for patients on
warfarin treatment.
This study was not without limitations. First, it
was conducted among patients in one clinic in
one hospital, and among specific patients, so this
limits the generalizability of the study to all
patients in the region or the entire country. Sec-Please cite this article in press as: Eltayeb T.Y.M. et al., Satisfaction with
Sudanese patients, J Saudi Heart Assoc (2016), http://dx.doi.org/10.1016/j.jondly, the scarcity of options of valid and reliable
instruments to measure satisfaction related to
Oral Anticoagulant Treatment (OAT) allowed us
too few choices and at this point, there is not
enough evidence that the measures we used are
the best ones for the Sudanese population. Finally,
self-reported method was adopted to measure
patients’ adherence to therapy. In this respect,
patients’ responses were subjected to recall bias
or they may not give the truth.Conclusions
Nearly half of the patients were considered as
satisfied with warfarin treatment Satisfaction with
warfarin treatment was higher among patients
who had current jobs and those with secondary
education and above. Adherence to warfarin treat-
ment was very low and no definite background
characteristic variable was found to be associated
with this domain.Recommendations
Ensuring adequate health education on warfarin
together with motivating patients is needed,
specifically among illiterate patients and those
with low educational level. Efficient multidisci-
plinary efforts from all healthcare providers
are needed to make warfarin treatment more
successful. Special efforts are needed from clinical
pharmacists to develop and implement an antico-
agulation clinical pharmacy service at hospital.References
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